Additional outcomes for participants with type 1 diabetes during control and intervention periods (n = 16).
BLOOD
Data presented for n = 16 (completers), except calcium (n = 15), corrected calcium (n = 15), phosphate (n = 15), uric acid (n = 15), magnesium (n = 15), creatine kinase (n = 15), and body weight (n = 13) due to missing data at ≥1 timepoint. Data for pre-control, post-control, and post-intervention timepoints presented as means and standard deviations or medians and interquartile ranges (indicated by ^). * = P<0.025. (DOCX)Click here for additional data file.Medtronic Australasia donated the necessary Continuous Blood Glucose Monitoring sensors and devices for participants throughout the study.Dr Lim and Dr Lee provided in-kind time to perform the roles of the study physician and study endocrinologist, respectively.